Furthermore, an siRNA-induced downregulation of HV1 inhibited proliferation, migration and invasion of both breast cancer, colorectal carcinoma and myeloid sarcoma cell lines, and a genetic HV1 deficiency delayed their growths in mouse tumor xenografts (15, 35–37). Here, HVCN1 is linked to breast carcinoma.